Edwards Lifesciences
837 hedge funds and large institutions have $25.5B invested in Edwards Lifesciences in 2018 Q2 according to their latest regulatory filings, with 82 funds opening new positions, 286 increasing their positions, 313 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $24.3B → $25.5B (+$1.16B)
0.55% more ownership
Funds ownership: 249.41% → 249.96% (+0.55%)
9% less repeat investments, than reductions
Existing positions increased: 286 | Existing positions reduced: 313
Holders
837
Holding in Top 10
22
Calls
$152M
Puts
$136M
Top Buyers
| 1 | +$242M | |
| 2 | +$195M | |
| 3 | +$113M | |
| 4 |
WCM Investment Management
Laguna Beach,
California
|
+$65.9M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$59.3M |
Top Sellers
| 1 | -$92.4M | |
| 2 | -$83.8M | |
| 3 | -$74.6M | |
| 4 |
Two Sigma Advisers
New York
|
-$74.5M |
| 5 |
Bank of New York Mellon
New York
|
-$73.7M |